Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Role of probiotics in the prevention and treatment of meticillin-resistant Staphylococcus aureus infections. β
Go to Publication β
International journal of antimicrobial agents (Int J Antimicrob Agents ) Vol: 42 Issue 6 Pages: 475-81 Pub: 2013 Dec Epub: 2013 Sep 7 Authors Sikorska H , Smoragiewicz W , |
|
|
Effects of Probiotics on Gut Microbiota in Patients with Inflammatory Bowel Disease: A Double-blind, Placebo-controlled Clinical Trial. β
Go to Publication β
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi (Korean J Gastroenterol ) Vol: 65 Issue 4 Pages: 215-21 Pub: 2015 Apr Epub: Authors Shadnoush M , Hosseini RS , Khalilnezhad A , Navai L , Goudarzi H , Vaezjalali M , |
|
|
Effect of Bacillus subtilis CGMCC 1.1086 on the growth performance and intestinal microbiota of broilers. β
Go to Publication β
Journal of applied microbiology (J Appl Microbiol ) Vol: 120 Issue 1 Pages: 195-204 Pub: 2016 Jan Epub: 2015 Nov 18 Authors Li Y , Xu Q , Huang Z , Lv L , Liu X , Yin C , Yan H , Yuan J , |
|
|
Effects of two different probiotics on microflora, morphology, and morphometry of gut in organic laying hens. β
Poultry science (Poult Sci ) Vol: 95 Issue 11 Pages: 2528-2535 Pub: 2016 Nov 1 Epub: 2016 May 3 Authors Forte C , Acuti G , Manuali E , Casagrande Proietti P , Pavone S , Trabalza-Marinucci M , Moscati L , Onofri A , Lorenzetti C , Franciosini MP , |
|
|
Simultaneous Supplementation of <i>Bacillus subtilis</i> and Antibiotic Growth Promoters by Stages Improved Intestinal Function of Pullets by Altering Gut Microbiota. β
Go to Publication β
Frontiers in microbiology (Front Microbiol ) Vol: 9 Issue Pages: 2328 Pub: 2018 Epub: 2018 Oct 12 Authors Li X , Wu S , Li X , Yan T , Duan Y , Yang X , Duan Y , Sun Q , Yang X , |
|
|
Prevention and Alleviation of Dextran Sulfate Sodium Salt-Induced Inflammatory Bowel Disease in Mice With Bacillus subtilis-Fermented Milk via Inhibition of the Inflammatory Responses and Regulation of the Intestinal Flora. β
Go to Publication β
Frontiers in microbiology (Front Microbiol ) Vol: 11 Issue Pages: 622354 Pub: 2020 Epub: 2021 Jan 7 Authors Zhang X , Tong Y , Lyu X , Wang J , Wang Y , Yang R , |
|
|
Modulatory Effects of Bacillus subtilis on the Performance, Morphology, Cecal Microbiota and Gut Barrier Function of Laying Hens. β
Animals : an open access journal from MDPI (Animals (Basel) ) Vol: 11 Issue 6 Pages: Pub: 2021 May 24 Epub: 2021 May 24 Authors Zhang G , Wang H , Zhang J , Tang X , Raheem A , Wang M , Lin W , Liang L , Qi Y , Zhu Y , Jia Y , Cui S , Qin T , |
|
|
Bacillus subtilis Attenuates Hepatic and Intestinal Injuries and Modulates Gut Microbiota and Gene Expression Profiles in Mice Infected with Schistosoma japonicum. β
Go to Publication β
Frontiers in cell and developmental biology (Front Cell Dev Biol ) Vol: 9 Issue Pages: 766205 Pub: 2021 Epub: 2021 Nov 16 Authors Lin D , Song Q , Zhang Y , Liu J , Chen F , Du S , Xiang S , Wang L , Wu X , Sun X , |
|
|
Effect of Probiotic Supplementation on the Gut Microbiota Composition of Infants Delivered by Cesarean Section: An Exploratory, Randomized, Open-label, Parallel-controlled Trial. β
Go to Publication β
Current microbiology (Curr Microbiol ) Vol: 80 Issue 11 Pages: 341 Pub: 2023 Sep 15 Epub: 2023 Sep 15 Authors Gong Y , Zhong H , Wang J , Wang X , Huang L , Zou Y , Qin H , Yang R , |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
